Lung cancer: open trials in Spain

271 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Micancer Center S.L.P., Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-06
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de Badajoz, Badajoz · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital del Mar, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Regional de Málaga, Málaga · Hospital Universitario Central De Asturias, Oviedo · University Hospital Son Espases, Palma · Hospital Universitario Marqués de Valdecilla, Santander · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clínico Universitario de Valladolid, Valladolid
Registry updated 2026-11-06
NCT06881784
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Trial Treatment · Phase 3 · Revolution Medicines, Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario de Jaén, Jaén · Hospital de Jerez de la Frontera, Jerez de la Frontera · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario Regional de Málaga, Málaga · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-06
NCT07284121
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Research · Hoffmann-La Roche
Complejo Hospitalario Universitario de Albacete, Albacete · Hospital Universitario Mancha Centro (Alcázar de San Juan);Servicio de digestivo, Alcázar de San Juan · Hospital Universitario Mancha Centro (Alcázar de San Juan);Servicio de oncología, Alcázar de San Juan · Hospital General Univ. de Alicante, Alicante · Hospital General de Alicante;servicio de digestivo, Alicante · Complejo Hospitalario Torrecardenas, Almería · Hospital de Badajoz, Badajoz · Hospital de Cruces, Barakaldo · Hospital Clinic i Provincial, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital de Cruces, Bilbao · Hospital General de Ciudad Real, Ciudad Real · Hospital Universitario San Cecilio, Granada · Hospital General Universitario de Guadalajara, Guadalajara · Hospital Sant Joan de Deu de Manresa;Servicio oncologia, Manresa · Hospital General Universitario J.M Morales Meseguer, Murcia · Hospital Virgen de Arrixaca;servicio de digestivo, Murcia · Hospital Univ. Central de Asturias, Oviedo · Hospital Son Espases, Palma de Mallorca · Complejo Hospitalario de Pontevedra, Pontevedra · Hospital Universitario Puerto Real, Puerto Real · Hospital Universitari Sant Joan de Reus, Reus · Hospital Universitario de Canarias, Santa Cruz de Tenerife · Complejo Hospitalario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife · Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela · Hospital Virgen del Rocio;Servicio de digestivo, Seville · Hospital de Toledo;Servicio de digestivo, Toledo · Hospital de Toledo;servicio de oncologia, Toledo · Hospital Arnau de Vilanova (Valencia) Servicio de Oncologia, Valencia · Hospital Clínico Universitario de Valladolid, Valladolid · Hospital Clinico Universitario Valladolid, Valladolid · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-11-06
NCT07659782
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Trial Treatment · Phase 2 · Verastem, Inc.
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital HM Nou Delfos, Barcelona · Hospital San Pedro, Logroño · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Ramón y Cajal, Madrid
Registry updated 2026-11-06
NCT07699328
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 1/2 · Voronoi, Inc
Institut Catala d'Oncologia, Badalona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Regional de Málaga, Málaga
Registry updated 2026-11-06
NCT05789082
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Hospital Germans Trias i Pujol, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-05
NCT06793215
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · ICO L'Hospitalet, Barcelona · Hospital Clínic i Provincial de Barcelona, Barcelona · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Universitario La Paz, Madrid · Hospital Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Clinica Universidad de Navarra Madrid, Madrid · Hospital Clinico Universitario Virgen de La Victoria, Málaga · Hospital Universitario Son Espases, Palma de Mallorca · Clinica Universitaria de Navarra, Pamplona · Hospital Universitario Marqués de Valdecilla, Santander · Hospital Universitario Virgen Macarena, Seville · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-05
NCT07090499
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-05
NCT07144280
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Pfizer
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario de Badajoz, Badajoz · Institut Catala d'Oncologia, Badalona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Clínico San Cecilio, Granada · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · University Hospital Son Espases, Palma · Hospital Universitario Virgen De Valme, Sevilla · Hospital Universitario Y Politecnico La Fe, Valencia · Consorcio Hospital General Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-05
NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Hospital Universitario de Cruces, Barakaldo · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital del Mar, Barcelona · Institut Català d'Oncologia, Girona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Hospital Universitario Virgen De La Macarena, Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-05
NCT07491497
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Trial Treatment · Phase 1/2 · TRIANA Biomedicines, Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Micancer Center S.L.P., Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro, Logroño · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid
Registry updated 2026-11-05
NCT07519655
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Trial Treatment · Phase 1 · Pfizer
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-05
NCT07563738
A 2-part Phase 1/2 Open-label Trial on ODM-212
Trial Treatment · Phase 1/2 · Orion Corporation, Orion Pharma
HM Nou Delfos, Barcelona · ICO Hospitale, Barcelona · Vall d'Hebron University Hospital, Barcelona · START Madrid-FJD, Madrid · Hospital 12 de Octubre, Madrid · HM Sanchinarro, Madrid
Registry updated 2026-11-05
NCT06119581
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitario Infanta Cristina, Badajoz · Hospital Universitario de Cruces, Barakaldo · Hospital del Mar, Barcelona · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital de Jerez de la Frontera, Jerez de la Frontera · Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria · Hospital Universitario De Leon, León · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Regional de Málaga, Málaga · University Hospital Son Espases, Palma · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Hospital Clinico Universitario de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-04
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06452277
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 3 · Bayer
Complexo Hospitalario Universitario A Coruña, A Coruña · Institut Catala d'Oncologia, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-04
NCT06561685
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-04
NCT06695845
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Trial Treatment · Phase 2 · Jazz Pharmaceuticals
Hospital Universitario Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Insular Gran Canarias, Las Palmas · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Regional Universitario de Malaga - Hospital General, Málaga · Complejo Hospitalario de Navarra, Pamplona · INCLIVA-Hospital Clínico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06890598
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 3 · Eli Lilly and Company
Hospital Infanta Cristina, Badajoz · Parc de Salut Mar - Hospital del Mar, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet · Hospital Jerez de la Frontera, Jerez de la Frontera · Hospital Insular de Gran Canaria, Las Palmas de Gran Canaria · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · H.R.U Málaga - Hospital General, Málaga · Hospital Universitari Son Espases, Palma · Complejo Hospitalario de Navarra, Pamplona · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · CHUS - Hospital Clinico Universitario, Santiago de Compostela · Hospital Universitario Virgen del Rocio, Seville · Hospital Clínico de Valencia, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2026-11-04
NCT07492680
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Trial Treatment · Phase 2 · Bristol-Myers Squibb
Hospital Universitari Vall d'Hebron, Barcelona · Hospitalet · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Virgen del Rocio, Seville
Registry updated 2026-11-04
2022-502959-54-00
A Phase 3, Open-Label, Randomized, Multi-Center Study of DZD9008 versus Platinum-Based Doublet Chemotherapy as First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertion Mutation
Trial Treatment · Phase 3 · Dizal Pharmaceutical Co. Ltd.
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Institut Català d'Oncologia, Girona · Hospital Universitario 12 de Octubre, Madrid · University Clinic of Navarra, Madrid · University Clinic of Navarra, Pamplona · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-11-03
2025-522495-84-00
A Clinical study of MK-4716 in people with certain solid tumors (MK-4716-001)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Fundación Jiménez Díaz, Madrid
Registry updated 2026-11-03
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Infantil Universitario Nino Jesus, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-11-03

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error